To assess JAM-A expression in myeloid cells infiltrating human tumors, we collected surgical tumor specimens from non-small cell lung cancer (NSCLC) patients and examined cell surface JAM-A expression via flow cytometry (Figure 2E, see Supplementary Figure 1 for gating strategy). Here, F11R is linked to non-small cell lung carcinoma.